Setting new standards in information exchange for the pharmaceutical and biotech industry
What to Expect at DPharm 2017
July 20, 2017
The Conference Forum has announced the 7th annual DPharm: Disruptive Innovations to Advance Clinical Trials event on September 7 and 8, 2017 in Boston.
As the annual event the life science industry can rely on for the latest thinking in clinical trials for 21st century drug development, the conference promises to challenge conventional thinking and inspire new ideas. Here is a brief summary of what you can look forward to at this year’s event.
Pre-Conference Workshop – September 6, 2017
Kicking off the proceedings is an optional pre-conference, hands-on workshop in which you get to be an innovator! Led by Barry Crist, Lead Investigator, Lilly Clinical Open Innovation Team, Eli Lilly & Company, attendees work with a small team to brainstorm and design an innovation to assist participants in Clinical Trials using co-design and human-centered approaches with tools such as Ambient Intelligence, the Internet of Things and Smart Devices.
Day One – September 7, 2017
Co-chairs Andreas Koester, MD, PhD, VP, Innovation, R&D Operations, Janssen, Craig Lipset, MBA, Head of Clinical Innovation, Pfizer, Inc and Bray Patrick-Lake, MFS, Director of Stakeholder Engagement, Duke Clinical Research Institute, provide the opening remarks for the event, which is broken down into four parts.
Part I focuses on “Patients, Innovation and Disruption” with sessions on: what R&D executives want to disrupt; how to bootstrap innovation; ADAPTABLE, a new system to do clinical trials; busting the myth that you can’t bring a trial to the patient; and turning opportunity into reality.
After lunch, Part II deals with “New Ideas and Progress.” Sessions include: patient disrupters as the ultimate partner; a case study on Turbo Tax for clinical trials; a choice of two tracks allowing you to hear from either companies who have previously presented their innovation at DPharm or companies presenting for the first time; and DPharm Idol 2017. The day concludes with the DPharm Annual Reception.
Day Two – September 8, 2017
Our event co-chairs open day two by announcing the winner of DPharm Idol 2017.
Part III of the event covers “The Next Generation of Ideas”. Included in this section are sessions on: the historic opportunity to use blockchain for drug development; how to align incentives to share clinical data; innovative projects with guest speakers interviewed by co-chair Craig Lipset; engaging patients by giving them their data; building a strategic community of patients; and a choice of three tracks centering on new digital innovations.
Part IV brings together a series of brief, impactful sessions from all stakeholders on: the NHS Patient Ambassador Program; Eli Lilly’s Hero’s Journey Project; investing in digital biomarkers; monitoring patients remotely by wireless; the strategic priorities of TransCelerate; and the Data Donation App.
To find out more about DPharm 2017, click here for full event details.